|Articles|May 8, 2023

Pharma 2023: New Rules for Clinical Lay Summaries in EU

Estelle Jobson, EUPATI alumna, patient expert and health communications professional discusses changes to the EU's requirements for clinical trial lay summaries.

Estelle Jobson, EUPATI alumna, patient expert and health communications professional discusses changes to the EU's requirements for clinical trial lay summaries at Pharma 2023.

EUPATI offers the following resources for sponsors looking for information on lay summaries:

Patients Involved – Patient feedback on a plain language summary of results

Good Lay Summary Practice – This “Good Lay Summary Practice” is identical to the content of the Good Lay Summary Practice Guidance published on EudraLex, Volume 10, 4 October 2021.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Articles

FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
September 11th 2025
How Recent Policy Changes Could Impact Clinical Research
September 10th 2025
Ensuring Digital Trial Platforms Work for Underserved Communities
September 10th 2025
eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Using AI Trial-Matching Tools to Accelerate Patient Access
September 8th 2025

Trending on Applied Clinical Trials Online

Latest NIMBLE Study Results Highlight Progress in gMG Research

Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients

Q&A: Strategies for Successful Global Clinical Trial Delivery

Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients

© 2025 MJH Life Sciences^®

All rights reserved.